ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $382,000 | +9.5% | 82,955 | +0.8% | 0.00% | – |
| Q3 2016 | $349,000 | +98.3% | 82,269 | +12.2% | 0.00% | – |
| Q2 2016 | $176,000 | +2.3% | 73,307 | +100.7% | 0.00% | – |
| Q1 2016 | $172,000 | +22.9% | 36,525 | +2.2% | 0.00% | – |
| Q4 2015 | $140,000 | +1.4% | 35,750 | 0.0% | 0.00% | – |
| Q3 2015 | $138,000 | -17.4% | 35,750 | -1.8% | 0.00% | – |
| Q2 2015 | $167,000 | – | 36,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |